Clinical Trials Logo

Osteoarthritis Hand clinical trials

View clinical trials related to Osteoarthritis Hand.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06038331 Not yet recruiting - Osteoarthritis Hand Clinical Trials

Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of STT Osteoarthritis

Start date: January 2024
Phase: Phase 2
Study type: Interventional

The aim of this open, prospective, multicenter trial is to evaluate the use of a sterile, devitalized, processed umbilical cord amniotic membrane implant placed in joint interposition in the treatment of STT osteoarthritis.

NCT ID: NCT06034262 Not yet recruiting - Osteoarthritis Hand Clinical Trials

Use of a Treated, Devitalized and Sterile Umbilical Cord Amniotic Membrane in the Treatment of PIP Joint Osteoarthritis

Start date: January 2024
Phase: Phase 2
Study type: Interventional

The aim of this open, prospective, multicenter trial is to evaluate the use of a sterile, devitalized, processed umbilical cord amniotic membrane implant placed in joint interposition in the treatment of PIP joint osteoarthritis.

NCT ID: NCT05351060 Not yet recruiting - Clinical trials for Rheumatoid Arthritis

Novel Splinting Technique Using 3D Models

Start date: May 16, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to determine the feasibility of a non-contact custom splint fabrication method for patients with chronic diseases suffering from hypersensitive skin or compromised skin integrity. Custom splinting by occupational therapists involves molding low-temperature thermoplastic material directly on patients' skin; however, skin sensitivity is a contraindication for splint fabrication. The study aims to recruit 10 male or female patients with either a diagnosis of scleroderma (SSc) or arthritis. A scan of the patient's hand and a 3D printer will be used to create a precise model of a patient's hand on which a custom splint will be fabricated. By taking this approach, traditional splinting is substituted by avoiding direct contact with the material on the surface of the patient's upper extremity. This technique creates therapeutic opportunities for underserved patients by expanding splinting options for patients with scleroderma and arthritis, and addressing the challenges associated with managing chronic diseases.